Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review

被引:0
|
作者
Crowley, Alexandra V. [1 ]
Banfield, Megan [1 ]
Gupta, Aditi [1 ]
Raj, Rhea [1 ]
Gorantla, Vasavi R. [2 ]
机构
[1] St Georges Univ, Sch Med, St Georges, Grenada
[2] West Virginia Sch Osteopath Med, Biomed Sci, Lewisburg, PA USA
关键词
pulmonary hypertension; anticoagulants; balloon pulmonary angioplasty (bpa); pulmonary endarectomy; (pea); thrombus; chronic thromboembolic pulmonary hypertension (cteph); ANGIOPLASTY; ENDARTERECTOMY; OUTCOMES; STATEMENT; RIOCIGUAT; EFFICACY; THERAPY; LIFE;
D O I
10.7759/cureus.53336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic thromboembolic pulmonary hypertension (CTEPH) is underdiagnosed and has recently surfaced as one of the leading triggers of severe pulmonary hypertension. This disease process is described by structural changes of pulmonary arteries such as fibrous stenosis, complete obliteration, or the presence of a resistant intraluminal thrombus, resulting in increased pulmonary resistance and eventually progressing to rightsided heart failure. Hence, this study aims to describe the current treatments for CTEPH and their efficacy in hemodynamic improvement and prevention of recurring thromboembolic episodes in patients. This systematic review promptly follows the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. On February 13, 2022, our team searched through the following databases: PubMed, ProQuest, and ScienceDirect. The following keywords were used across all databases: CTEPH AND Pulmonary Endarterectomy (PEA), CTEPH AND Balloon Pulmonary Angioplasty (BPA), and CTEPH AND Medical Therapy OR Anticoagulation therapy. Twenty-nine thousand eighty-nine articles on current management techniques (PEA, Balloon angioplasty, anticoagulants) were selected, analyzed, and reviewed with each other. We found 19 articles concerning PEA, 15 concerning BPA, and six regarding anticoagulants. Most papers showed high success rates and promising evidence of PEA and anticoagulants as a postoperative regimen. BPA was the least preferred but is still reputable in patients unfit for invasive techniques. CTEPH is a condition presenting with either fibrous stenosis, complete obliteration of the artery, or a clogged thrombus. Recent studies have shown three techniques that physicians have used to treat CTEPH: balloon-pulmonary angioplasty, PEA, and medical management with anticoagulants. PEA followed by anticoagulants is preferred to balloon pulmonary angioplasties. CTEPH is an ongoing topic in research; as it continues to be researched, we hope to see more management techniques available.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Chronic thromboembolic pulmonary hypertension: evolution in management
    LeVarge, Barbara L.
    Channick, Richard N.
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) : 400 - 408
  • [32] Advances in the Management of Chronic Thromboembolic Pulmonary Hypertension
    Papamatheakis, Demosthenes G.
    Kim, Nick H.
    CURRENT HYPERTENSION REPORTS, 2015, 17 (09)
  • [33] Epidemiology and management of chronic thromboembolic pulmonary hypertension
    Klok, F. A.
    Huisman, M. V.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (09): : 347 - 351
  • [34] Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension
    Yang, Jenny
    Madani, Michael M.
    Mahmud, Ehtisham
    Kim, Nick H.
    CHEST, 2023, 164 (02) : 490 - 502
  • [35] Advances in the Management of Chronic Thromboembolic Pulmonary Hypertension
    Demosthenes G. Papamatheakis
    Nick H. Kim
    Current Hypertension Reports, 2015, 17
  • [36] A roadmap for management of chronic thromboembolic pulmonary hypertension
    Jais, Xavier
    Brenot, Philippe
    Montani, David
    Fadel, Elie
    Humbert, Marc
    Simonneau, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (04)
  • [37] An Update on the Management of Chronic Thromboembolic Pulmonary Hypertension
    Edward, Justin A.
    Mandras, Stacy
    CURRENT PROBLEMS IN CARDIOLOGY, 2017, 42 (01) : 7 - 38
  • [38] RIOCIGUAT FOR THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Larche, N. E.
    Mousa, S. A.
    DRUGS OF TODAY, 2013, 49 (12) : 761 - 768
  • [39] Chronic thromboembolic pulmonary hypertension: an updated review
    Lang, Irene M.
    Klepetko, Walter
    CURRENT OPINION IN CARDIOLOGY, 2008, 23 (06) : 555 - 559
  • [40] Therapies of chronic thromboembolic pulmonary hypertension: A review
    Vasiltseva, Oksana Ya.
    Edemskiy, Alexander G.
    Zeinalov, Devran F.
    Kliver., Elena N.
    Ussov, Wladimir Yu.
    Grankin, Denis S.
    Sirota, Dmitry A.
    Chernyavskiy, Aleksandr M.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (01) : 58 - 62